Profile details
关于 Laura Zhu
Laura is an associate in the Life Sciences Transactions team of our New York office. Prior to joining Freshfields, Laura worked at a global law firm where she represented clients in complex trade secret and patent litigation matters involving diverse technologies.
近期项目经验
- Grünenthal on its acquisition of Valinor Pharma and its product Movantik® (naloxegol).
- CVC on its $925m acquisition of Therakos from Mallinckrodt.
- Novartis in its global license agreement with Monte Rosa Therapeutics for VAV1-directed molecular glue degraders.
- SERB Pharmaceuticals on its acquisition of RSDL® (Reactive Skin Decontamination Lotion) kit from Emergent BioSolutions Inc.
- Johnson & Johnson on its $13.1 billion pending acquisition of Shockwave Medical, Inc.
执业资质
- New York University School of Law, J,D., 2020
- Executive Editor, Journal of Intellectual Property and Entertainment Law
- Columbia University, B.S., Chemical Engineering, cum laude, 2015